Claim Missing Document
Check
Articles

Found 24 Documents
Search

Penyuluhan dan Pemeriksaan Kristal Kalsium Oksalat untuk Pencegahan Gangguan Saluran Kemih pada Warga Desa Ligarmukti, Kabupaten Bogor, Jawa Barat Purwanti, Angki; Lestari, Diah; Fajrunni'mah, Rizana
Inovasi Jurnal Pengabdian Masyarakat Vol 3 No 3 (2025): IJPM - Desember 2025
Publisher : CV Firmos

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54082/ijpm.944

Abstract

Air warga Desa Ligarmukti yang digunakan rutin untuk keperluan domestik bersifat sadah. Akibatnya warga mengalami gangguan kesehatan seperti nyeri pinggang, sulit berkemih dan anyang-anyangan. Tujuan pengabdian melakukan identifikasi kristal kalsium oksalat pada urin warga dan meningkatkan pengetahuan warga agar dapat meminimalkan adanya kristal kalsium oksalat dalam urin. Peningkatan pengetahuan dilakukan melalui ceramah dibantu media leaflet serta poster dan pemeriksaan kristal kalsium oksalat dengan metode mikroskopis.  Evaluasi dilihat dari rerata persentase kenaikan skor pre dan post test. Hasil identifikasi negatif dan positif kristal kalsium oksalat sebanyak 40 (62,5%) orang dan 24 (37,5%) orang dengan 17 orang positif satu dan 7 orang positif dua. Rerata skor pre test di RT 06, RT 11, RT 12 adalah 1,8, 1,4, 2,27. Rerata skor post test di ketiga RT adalah 6,6, 5,2, 6,7.  Persentase kenaikan skor pre dan post test di ketiga RT adalah 72,7%, 73,1%, 66,1%. Dari kegiatan pengabdian ini diketahui terdapat gangguan urinasi warga desa akibat pembentukan kristal kalsium oksalat. Penyuluhan pada pengadian ini meningkatkan pengetahuan warga desa untuk meminimalkan adanya kristal kalsium oksalat dalam saluran urin dengan cara mengurangi konsumsi makanan dan minuman tinggi oksalat serta konsumsi rebusan TOGA yang dapat meluruhkan kristal kalsium oksalat.
Status Kadar Antibodi Spike Receptor Binding Domain setelah Vaksinasi Kedua menggunakan Vaksin Inaktivasi Fajrunni'mah, Rizana; Purwanti, Angki; Khasanah, Furaida; Setiawan, Budi
Health Information : Jurnal Penelitian Vol 14 No 2 (2022): Juli-Desember
Publisher : Poltekkes Kemenkes Kendari

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36990/hijp.v14i2.636

Abstract

Coronavirus Disease 2019 (COVID-19) adalah penyakit menular yang disebabkan oleh Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) yang berlangsung cukup cepat dan menyebar ke berbagai negara dalam waktu singkat. Vaksinasi merupakan salah satu upaya menanggulangi pandemi COVID-19. Salah satu jenis vaksin yang saat ini digunakan adalah vaksin dengan jenis inaktivasi. Tujuan penelitian ini untuk mengetahui kadar antibodi setelah vaksinasi kedua menggunakan jenis vaksin inaktivasi sebelum diberikan vaksinasi lanjutan ketiga, dan faktor-faktor yang mempengaruhinya. Penelitian menggunakan metode observasional yang berlokasi di Poltekkes Kemenkes Jakarta III selama Februari 2022, jumlah sampel sebanyak 33 orang. Pengukuran kadar antibodi S-RBD (receptor binding domain) SARS-CoV-2 kuantitatif menggunakan metode ECLIA dengan alat Cobas e-411. Setelah penelitian, kadar antibodi 100% reaktif dengan rentang yang bervariasi, kelompok tinggi (>250 U/mL) sebanyak 84,8%, menengah (117-250 U/mL) sebanyak 6,1%, dan rendah (<117 U/mL) sebanyak 9,1%. Terdapat hubungan antara indeks massa tubuh dengan kadar antibodi (p=0,046). Tidak terdapat hubungan antara jenis kelamin, usia, jarak waktu setelah vaksin kedua, riwayat COVID-19, dan riwayat komorbid dengan kadar antibodi. Vaksin COVID-19 jenis inaktivasi menginduksi respons antibodi kuat yang masih bertahan sebelum dilakukannya vaksinasi lanjutan ketiga.
Relationship between Procalcitonin Levels (PCT) and Disease Severity in Hospitalized Patients Confirmed Positive for COVID-19 Fajrunni'mah, Rizana; Rada, Fransiska; Widhyasih, Retno Martini
JURNAL INFO KESEHATAN Vol 20 No 1 (2022): JURNAL INFO KESEHATAN
Publisher : Research and Community Service Unit, Poltekkes Kemenkes Kupang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31965/infokes.Vol20.Iss1.638

Abstract

Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This disease attacks the respiratory tract and spreads rapidly almost throughout the world, hence, WHO has declared COVID-19 as a global pandemic. The presence of inflammation and bacterial co-infection in COVID-19 hospitalized patients can increase procalcitonin (PCT) levels as a biomarker of inflammation. Elevated PCT levels are also associated with disease severity. The objective of this study is to determine the relationship between PCT levels and disease severity in hospitalized patients who are confirmed positive for COVID-19. This research method is analytic observational with cross sectional design. The sample is in the form of medical record data for 180 COVID-19 patients who are hospitalized at Bhayangkara Tk. I Raden Said Sukanto Hospital, Jakarta for the period July-December 2020. The relationship between PCT levels and disease severity was statistically analyzed using the Chi Square test. The results of this study were 109 (60.6%) men and 71 (39.4%) women with the highest age group being 46-59 years. The average PCT level was 10.38 ng/mL with the lowest level of 0.01 ng/mL and the highest level of 282.00 ng/mL. PCT levels <0.5 ng/mL were discovered in 111 patients (61.7%) and PCT levels 0.5 ng/mL in 69 patients (38.3%). The severity of disease in mild-moderate illness was 87 patients (48.4%), severe was 35 patients (19.4%), and critical was 58 patients (32.2%). The Chi Square test showed that there was a relationship between PCT levels and disease severity in COVID-19 patients (p = 0.000). The higher the PCT level, the higher the severity of the disease, thus, PCT can be used as an indicator to see the severity of the disease.
Relationship Between CD4+ Cell with GenExpert Molecular Mycobacterium tuberculosis Test in HIV/AIDS patients Al’fira Gita Islami; Rizana Fajrunni'mah; Mega Mirawati
Health Media Vol. 3 No. 2 (2022)
Publisher : UrbanGreen

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55756/hm.v3i2.67

Abstract

CD4+ cells in HIV/AIDS patients is an examination that serves to monitor the regulation of the immune system. HIV/AIDS patients experience a decrease in the number of CD4+ cells which results in various opportunistic infections, one of which is caused by Mycobacterium tuberculosis. This study aims to determine the relationship between the results of CD4+ cell with GenExpert Molecular Mycobacterium tuberculosis Test. This study was based on an analytic observational cross-sectional design on 53 samples of HIV/AIDS patients at Budhi Asih Hospital. Data analyze using Fisher Exact statistical test with α = 0.05. The result showed percentage CD4+ cells <200 with positive TCM result 48 (86,4%). CD4+ cells >200 with GenExpert positif result 0 (0,0%). The results showed that there was no relationship between CD4+ cell examination and TCM GenExpert MTB examination in HIV/AIDS patients (p = 0.574). From the result we can conclude that maybe other infection has happened.